Citation
Godsland, I F., et al. "Coronary Calcification, Homocysteine, C-reactive Protein and the Metabolic Syndrome in Type 2 Diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease By Coronary Tomography (PREDICT) Study." Diabetic Medicine : a Journal of the British Diabetic Association, vol. 23, no. 11, 2006, pp. 1192-200.
Godsland IF, Elkeles RS, Feher MD, et al. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med. 2006;23(11):1192-200.
Godsland, I. F., Elkeles, R. S., Feher, M. D., Nugara, F., Rubens, M. B., Richmond, W., Khan, M., Donovan, J., Anyaoku, V., & Flather, M. D. (2006). Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabetic Medicine : a Journal of the British Diabetic Association, 23(11), 1192-200.
Godsland IF, et al. Coronary Calcification, Homocysteine, C-reactive Protein and the Metabolic Syndrome in Type 2 Diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease By Coronary Tomography (PREDICT) Study. Diabet Med. 2006;23(11):1192-200. PubMed PMID: 17054594.
TY - JOUR
T1 - Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
AU - Godsland,I F,
AU - Elkeles,R S,
AU - Feher,M D,
AU - Nugara,F,
AU - Rubens,M B,
AU - Richmond,W,
AU - Khan,M,
AU - Donovan,J,
AU - Anyaoku,V,
AU - Flather,M D,
AU - ,,
PY - 2006/10/24/pubmed
PY - 2007/5/22/medline
PY - 2006/10/24/entrez
SP - 1192
EP - 200
JF - Diabetic medicine : a journal of the British Diabetic Association
JO - Diabet Med
VL - 23
IS - 11
N2 - AIMS: The PREDICT Study aims to determine: (i) the association between cardiovascular risk factors and coronary artery calcification score (CACS) obtained by electron beam tomography and (ii) the predictive value of CACS for coronary heart disease (CHD) events in Type 2 diabetes. METHODS: Having previously reported relationships between CACS and conventional risk factors, we have now studied the novel risk factors, plasma high-sensitivity C-reactive protein (CRP) and homocysteine, insulin resistance, serum apoprotein A1 and B concentrations, the serum triglyceride/high-density lipoprotein cholesterol ratio and metabolic syndrome (International Diabetes Federation definition) in 573 subjects of the PREDICT Type 2 diabetes cohort. RESULTS: In univariate analyses, the only significant positive novel correlate of CACS was homocysteine (P = 0.0004). CRP was increased in those with detectable calcification, but decreased with increasing calcification score (P = 0.006). In a multivariate model that included all significant univariate correlates, CACS was independently associated with age (P < 0.0001), waist-hip ratio (P < 0.02), male gender (P < 0.05) and duration of diabetes (P < 0.05), but the association with homocysteine was no longer significant. The negative association between CACS and CRP remained in multivariate analysis, and was independent of statin use. CONCLUSIONS: Age was the major factor influencing CACS in Type 2 diabetes, with weaker contributions from waist hip-ratio and duration of diabetes. Other novel cardiovascular risk factors appear to have little positive effect.
SN - 0742-3071
UR - https://www.unboundmedicine.com/medline/citation/17054594/Coronary_calcification_homocysteine_C_reactive_protein_and_the_metabolic_syndrome_in_Type_2_diabetes:_the_Prospective_Evaluation_of_Diabetic_Ischaemic_Heart_Disease_by_Coronary_Tomography__PREDICT__Study_
L2 - https://doi.org/10.1111/j.1464-5491.2006.01950.x
DB - PRIME
DP - Unbound Medicine
ER -